This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Booming Telehealth Market Lures More IPOs and M&A Deals
by Sapna Bagaria
To make the most of the booming telehealth industry, players are coming up with IPOs and resorting to mergers and acquisitions.
SOC Telemed (TLMD) Aids Virtual Service Expansion of SCP Health
by Sapna Bagaria
SOC Telemed (TLMD) offers its cloud-based Telemed IQ platform to expedite SCP Health's virtual care expansion.
Will Teladoc (TDOC) Feel the Heat From SOC Telemed's Expansion?
by Zacks Equity Research
SOC Telemed's fund-raising program through investors for the second consecutive year to expand its operations might intensify competition for Teladoc Health (TDOC).
Will Teladoc's (TDOC) New Service Seize the Mental Health Space?
by Zacks Equity Research
Teladoc Health (TDOC) rolls out a complete mental care offering to tap the growing market for behavioral health care.
Aurora Cannabis (ACB) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis' (ACB) sturdy consumer cannabis sales are likely to have benefited its performance in the fiscal third quarter.
Why American Well (AMWL) Might Surprise This Earnings Season
by Zacks Equity Research
American Well (AMWL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Schrodinger (SDGR) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Schrodinger's (SDGR) first-quarter results are likely to reflect benefits from collaborations.
What's in Store for Asensus Surgical's (ASXC) Q1 Earnings?
by Zacks Equity Research
Asensus Surgical's (ASXC) first-quarter results are likely to reflect benefits from regulatory approvals and collaboration.
American Axle (AXL) to Report Q1 Earnings: What Lies Ahead?
by Zacks Equity Research
American Axle's (AXL) Q1 results likely to reflect benefits of solid top-line growth across both of the company's segments during the January-March period.
Will Surging Sales in China Drive General Motors' (GM) Q1 Earnings?
by Zacks Equity Research
General Motors' (GM) enhanced product line-up and customer-centric offerings in China are likely to have boosted the auto giant's Q1 earnings.
Teladoc (TDOC) Q1 Earnings Beat, 2021 Revenue Guidance Up
by Zacks Equity Research
Teladoc's (TDOC) Q1 results reflect revenue increase, led by higher membership and visits, partly offset by flared-up expenses.
Here's Why Cummins (CMI) is Poised for Q1 Earnings Beat
by Zacks Equity Research
Cummins' (CMI) Q1 results likely to reflect gains from rising sales across all major segments during the March-end quarter.
Factors Shaping the Fate of General Motors' (GM) Q1 Earnings
by Zacks Equity Research
Rising vehicle deliveries in the United States and China likely to have boosted General Motors' (GM) margins during the January-March period.
Will Vaccine Under the Lens Aid Teladoc's (TDOC) Prospects?
by Zacks Equity Research
Teladoc Health (TDOC) is likely to gain as the J&J-AstraZeneca vaccine comes under the microscope. This will likely slacken the vaccination drive, causing investors to shift to at-home stocks.
Will Teladoc (TDOC) Survive Competition From Amazon's Entry?
by Zacks Equity Research
Teladoc's (TDOC) wide business scale, comprehensive product portfolio, wide clientele base, international operations poise it well to face competition from Amazon's foray into the virtual healthcare space.
Cigna (CI) Set to Expand in Telehealth Via MDLIVE Buyout
by Zacks Equity Research
Cigna (CI) is set to buy MDLIVE, a provider of telehealth services, to gain share in the growing market.
Medical Products' Feb 11 Earnings Roster: DXCM, LH & More
by Trina Mukherjee
The Medical Product companies' fourth-quarter results are likely to reflect huge adoption of COVID-19 related healthcare-support products and services despite the impact of the ongoing pandemic.
New Coronavirus Strain to Keep Telehealth Stocks in Demand
by Sapna Bagaria
Telemedicine is here to stay as the new coronavirus strain triggers a fear psychosis at large, thereby retaining solid demand for telehealth stocks.
Implied Volatility Surging for American Well (AMWL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to American Well (AMWL) stock based on the movements in the options market lately.
Teladoc (TDOC) and Dexcom Offer New Solutions for Diabetes
by Zacks Equity Research
Teladoc (TDOC) and Dexcom jointly provide solutions for patients with Type 2 diabetes, a common lifestyle-induced malady.
Is Competition Intensifying for Teladoc's (TDOC) Business?
by Zacks Equity Research
Teladoc (TDOC) might see heightening competition as Amazon fortifies its presence in telehealth space.
3 Telehealth Stocks to Keep Shaping the Future of Healthcare
by Sapna Bagaria
The need for touchless treatment, safety, ease, flexibility and efficiency in the current healthcare system makes telehealth a much sought-after option to provide care in the future.